KinesioTaping for Thoracic Drain Support (KT-Drain)

December 14, 2025 updated by: İsmail DAL, Kastamonu University

Effect of KinesioTaping on Pain at Mediastinal-Thoracic Tube Sites After Cardiac Surgery: A Randomized Prospective Study

This study investigates the effectiveness of KinesioTaping applied around mediastinal and thoracic drain sites in reducing postoperative pain after cardiac surgery. Effective pain management is critical for early mobilization, improved patient satisfaction, and prevention of respiratory complications such as atelectasis. KinesioTaping is theorized to support soft tissue healing, improve circulation, and modulate pain through stimulation of cutaneous mechanoreceptors and fascia adjustment. However, evidence on its efficacy in postoperative settings remains limited. This prospective, randomized controlled trial aims to provide high-quality data on the role of KinesioTaping as a non-pharmacological adjunct for pain management in patients undergoing cardiac surgery.

Study Overview

Detailed Description

Postoperative pain following cardiac surgery is a significant clinical concern that can hinder early mobilization, reduce patient satisfaction, prolong hospital stay, and increase the risk of respiratory complications such as atelectasis and pneumonia. While pharmacological analgesia remains the mainstay of treatment, non-pharmacological adjuncts are increasingly being explored to enhance pain control and reduce reliance on opioids.

KinesioTaping (KT), a method originally developed for musculoskeletal conditions, involves the application of elastic therapeutic tape to the skin with the aim of supporting soft tissue structures, enhancing lymphatic and blood flow, and modulating nociceptive input via stimulation of cutaneous mechanoreceptors. In the context of postoperative care, KT may also help reduce localized edema, support incision sites, and promote a sense of physical stability that contributes to pain relief.

Despite its growing popularity in rehabilitation and sports medicine, the use of KinesioTaping in postoperative settings-particularly in cardiothoracic surgery-remains under-investigated. Limited studies have suggested potential benefits in reducing pain and improving functional outcomes, but current evidence is inconclusive and often methodologically limited.

This prospective, randomized controlled trial aims to evaluate the effectiveness of KinesioTaping when applied around mediastinal and thoracic drain sites in patients undergoing cardiac surgery. The primary objective is to assess postoperative pain levels using validated pain scales (e.g., VAS) in patients receiving KT versus those receiving standard care without taping. Secondary outcomes include opioid consumption, time to ambulation, respiratory function (spirometry or incentive spirometry use), incidence of atelectasis, and patient satisfaction scores.

By providing high-quality evidence on a low-cost, non-invasive, and easily applicable intervention, this study seeks to clarify the potential role of KinesioTaping as an adjunctive tool in postoperative pain management protocols following cardiac surgery.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kastamonu
      • Kastamonu, Kastamonu, Turkey (Türkiye), 37200
        • Kastamonu Education and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Elective cardiac surgery cases
  • Patients who are stable until the removal of the chest drain
  • Patients who do not experience serious complications such as bleeding or neurological problems

Exclusion Criteria:

  • Patients undergoing emergency cardiac surgery,
  • Patients with early post-cardiac surgery mortality,
  • Patients with conditions requiring reoperation, such as bleeding,
  • Patients for whom a pain score cannot be measured, such as neurological complications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Kinesiotaping group
In this group, KinesioTaping will be applied alongside routine pain management.
In this group, KinesioTaping will be applied around the thoracic drain sites alongside standard analgesic therapy. This physical therapy technique uses elastic tapes placed on the skin to support healing, reduce pain, and improve patient comfort. The tapes will remain in place for 2-3 days and will be removed together with the drains.
Other Names:
  • Kinesiotape
Active Comparator: Routine treatment group
This group will be managed with standard hospital-based painkiller administration.
Patients in this group will be treated with painkillers consisting of tramadol and dexketoprofen.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Day 3 Visual Analogue Scale Pain Score
Time Frame: 3 day

Visual analog scale pain score on the 3th day after cardiac surgery. Pain is defined as no pain (0) or unbearable pain (10).

0 = No pain, 1-3 = Mild pain, 4-6 = Moderate pain, 7-10 = Severe pain

3 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2025

Primary Completion (Actual)

December 12, 2025

Study Completion (Actual)

December 12, 2025

Study Registration Dates

First Submitted

July 20, 2025

First Submitted That Met QC Criteria

July 29, 2025

First Posted (Actual)

August 1, 2025

Study Record Updates

Last Update Posted (Actual)

December 19, 2025

Last Update Submitted That Met QC Criteria

December 14, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

yes

IPD Sharing Time Frame

Data will become available persistantly on 2.2.2026.

IPD Sharing Access Criteria

Upon reasonable request principal investigator will share the data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary Condition: Pain, Postoperative

Clinical Trials on Kinesiotaping

Subscribe